Join to access to all OVN content. Join for Free
From Pharmacy to MSL: How an Rx background can lead to industry
pharmacy to industry transition pharmacy skills in MSL career networking for MSLs mentorship in MSL career transitioning to MSL role

From Pharmacy to MSL: How an Rx background can lead to industry


Share This Article


Summary

In this episode, Tom Caravela welcomes Cassie James to discuss her transition from pharmacy to the industry and how her pharmacy skills have been invaluable in her MSL career. Cassie shares insights from her fellowship experience and outlines essential steps for transitioning into industry roles. They explore the importance of networking, positioning, and key skills for aspiring MSLs, along with the challenges and experiences Cassie has faced in her career. The conversation highlights the significance of mentorship in the MSL career path and concludes with Cassie's final advice for aspiring MSLs.

My guest today is Kassey James, PharmD, MHA, Medical Science Liaison at Ashfield and we discuss how a Pharmacy background can lead to a role as a Medical Science Liaison

Kassey explains…

👉Why Pharmacists are good candidates for MSL positions

👉How Pharmacists can position themselves for industry roles

👉Advice on how to land a fellowship or internship

👉What skills need to be developed to transition to industry

👉What challenges exist for newer MSLs right now

Click for Source
pharmacy to industry transition, pharmacy skills in MSL career, networking for MSLs, mentorship in MSL career, transitioning to MSL role

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Types of Conferences MSLs Attend & How To Prepare...
Partner Avatar MSL Talk: Tom Caravela, George Lehman

Types of Conferences MSLs Attend & How To Prepare...

Podcast
Why Clinicians Make Great MSLs
Partner Avatar MSL Talk: Tom Caravela, Dawn O'Reilly

Why Clinicians Make Great MSLs

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Explore OVN